Agonist-antagonist properties of 5,7-ethano-4,5,5a,6,7,11b-hexahydro-2,6,7-trimethyl-1H-benzo[g]homoquinolin-9-ol and 4,6-ethano-3,4,4a,5,6,10b-hexahydro-2,5,6-trimethylbenzo[f]quinolin-8-ol.
D000700:Analgesics; D000818:Animals; D051379:Mice; D009292:Narcotic Antagonists; D010423:Pentazocine / Q000031:analogs & derivatives* / Q000494:pharmacology
D000700:Analgesics; D009292:Narcotic Antagonists; C039709:5,7-ethano-4,5,5a,6,7,11b-hexahydro-2,6,7-trimethyl-1H-benzo(g)homoquinolin-9-ol; C039710:4,6-ethano-3,4,4a,5,6,10b-hexahydro-2,5,6-trimethylbenzo(f)quinolin-8-ol; D010423:Pentazocine